Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.49 - $7.2 $192,858 - $309,261
-42,953 Closed
0 $0
Q2 2024

Aug 14, 2024

SELL
$4.33 - $6.79 $724,179 - $1.14 Million
-167,247 Reduced 79.57%
42,953 $210,000
Q1 2024

May 13, 2024

BUY
$4.03 - $7.81 $847,106 - $1.64 Million
210,200 New
210,200 $1.51 Million
Q1 2023

Oct 21, 2024

SELL
$3.74 - $7.46 $43,335 - $86,439
-11,587 Reduced 26.98%
31,366 $120,000
Q1 2023

May 03, 2023

BUY
$3.74 - $7.46 $71,980 - $143,575
19,246 Added 158.8%
31,366 $120,000
Q4 2022

Feb 13, 2023

BUY
$4.56 - $6.61 $55,267 - $80,113
12,120 New
12,120 $62,000
Q2 2022

Aug 09, 2022

SELL
$2.11 - $4.06 $77,859 - $149,814
-36,900 Closed
0 $0
Q1 2022

May 12, 2022

SELL
$2.73 - $11.94 $9,546 - $41,754
-3,497 Reduced 8.66%
36,900 $101,000
Q4 2021

Feb 10, 2022

BUY
$11.49 - $22.0 $464,161 - $888,734
40,397 New
40,397 $464,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $246M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.